We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Places Confidential Health Information at Risk

By HospiMedica International staff writers
Posted on 21 Jan 2019
Advances in artificial intelligence (AI) technologies, such as those incorporated into activity trackers, smartphones, and smartwatches, can threaten the privacy of personal health data.

Researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA), the University of California Berkeley (UCB; USA), and other institutions conducted a cross-sectional study of U.S. More...
National Health and Nutrition Examination Survey (NHANES) data sets to evaluate the feasibility of reidentifying accelerometer-measured physical activity data, which have had geographic and protected health information removed, using support vector machines (SVMs) and random forest machine learning methods.

The accelerometer-measured data were collected for seven continuous days, with the primary outcome being the ability of the random forest and linear SVM algorithms to match demographic and aggregated physical activity data to individual-specific record numbers, and the percentage of correct matches made by each algorithm. The results showed that random forest algorithm successfully reidentified the demographic and aggregated physical activity data of an average of 94% of the adults and 86% of the children. The linear SVM algorithm successfully reidentified demographic and physical activity data of 85% of the adults and 68% of the children. The study was published on December 21, 2018, in JAMA Network Open.

“The results point out a major problem; if you strip all the identifying information, it doesn't protect you as much as you'd think. Someone else can come back and put it all back together if they have the right kind of information,” said senior author Anil Aswani, PhD, of UCB, and colleagues. “You could imagine Facebook gathering step data from the app on your smartphone, then buying health care data from another company and matching the two. They could either start selling advertising based on that or they could sell the data to others.”

“Employers, mortgage lenders, credit card companies and others could potentially use AI to discriminate based on pregnancy or disability status, for instance. What I'd like to see from this are new regulations or rules that protect health data; but there is actually a big push to even weaken the regulations right now,” concluded Dr. Aswani. “The risk is that if people are not aware of what's happening, the rules we have will be weakened. And the fact is the risks of us losing control of our privacy when it comes to health care are actually increasing and not decreasing.”

Random forests are an ensemble learning method that combines a large number of decision trees to make predictions. Although random forest models are difficult to interpret, this approach is one of the most successful machine learning techniques because it often has the highest accuracy. Linear SVM is a popular classification algorithm that has fast computation speed, is easily interpretable, and has good accuracy.

Related Links:
Massachusetts Institute of Technology
University of California Berkeley


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Ureteral Dilatation Balloon
Dornier Equinox
New
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A microneedle array worn on top of the wrist measures glucose, alcohol and lactate levels in the interstitial fluid under the skin (Photo courtesy of An-Yi Chang/UC San Diego)

Wristband Sensor Provides All-In-One Monitoring for Diabetes and Cardiovascular Care

Diabetes management is a complex and evolving challenge, particularly when it comes to accurately tracking and understanding how various factors affect blood sugar levels and overall health.... Read more

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.